Advertisement

The Latest

The U.S. Drug Enforcement Administration has extended its pandemic-era controlled drug rules, which were set to end May 11 with the end of the COVID-19 public health emergency, according to a May 10 report from Medscape.

The telemedicine industry is expected to experience a compound annual growth rate of 21.4 percent through 2031, reaching a value of more than $435 billion, according to market analysis published May 10 in Digital Journal.

Nearly 90 prior authorization reform bills in 30 states are being considered in the most recent legislative sessions, the American Medical Association said in a May 10 blog post.  

Advertisement